150 related articles for article (PubMed ID: 9539094)
1. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
[TBL] [Abstract][Full Text] [Related]
2. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allografted meth A (H-2d) tumor cells in C57BL/6 (H-2b) mice.
Nomi H; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
Microbiol Immunol; 2007; 51(3):297-306. PubMed ID: 17380049
[TBL] [Abstract][Full Text] [Related]
3. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
[TBL] [Abstract][Full Text] [Related]
5. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
6. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
[TBL] [Abstract][Full Text] [Related]
7. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
9. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
Yoneda Y; Yoshida R
J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
[TBL] [Abstract][Full Text] [Related]
10. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
11. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.
Tashiro-Yamaji J; Einaga-Naito K; Kubota T; Yoshida R
Microbiol Immunol; 2006; 50(2):105-16. PubMed ID: 16490928
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ Control of an Effector/Target Combination for Skin Allograft Rejection: Macrophage/Skin Components in Normal Mice or T Cell/Endothelial Cells in IFN-γ-Deficient Mice.
Yoshida R; Maeda S; Tashiro-Yamaji J; Yasuda E; Shibayama Y; Hirose Y; Kubota T
J Interferon Cytokine Res; 2020 Apr; 40(4):207-217. PubMed ID: 32069165
[TBL] [Abstract][Full Text] [Related]
13. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
14. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
15. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
[TBL] [Abstract][Full Text] [Related]
16. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
Ushio-Umeda Y; Yoshida R
Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
[TBL] [Abstract][Full Text] [Related]
18. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
[TBL] [Abstract][Full Text] [Related]
19. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
Cleven HA; Genden EM; Moran TM
Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
